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Programmed cell death (PCD) can play a crucial role in tuning the immune response
to microbial infection. Although PCD can occur in different forms, all are mediated
by a family of proteases called caspases. Caspase-2 is the most conserved caspase,
however, its function in cell death is ill-defined. Previously we demonstrated that live
attenuated cattle vaccine strain Brucella abortus RB51 induces caspase-2-mediated and
caspase-1-independent PCD of infected macrophages. We also discovered that rough
attenuated B. suis strain VTRS1 induces a caspase-2-mediated and caspase-1-independent
proinflammatory cell death in infected macrophages, which was tentatively coined
“caspase-2-mediated pyroptosis”. However, the mechanism of caspase-2-mediated cell
death pathway remained unclear. In this study, we found that caspase-2 mediated
proinflammatory cell death of RB51-infected macrophages and regulated many genes in
different PCD pathways. We show that the activation of proapoptotic caspases-3 and -8
was dependent upon caspase-2. Caspase-2 regulated mitochondrial cytochrome c release
and TNFα production, both of which are known to activate caspase-3 and caspase-8,
respectively. In addition to TNFα, RB51-induced caspase-1 and IL-1β production was also
driven by caspase-2-mediated mitochondrial dysfunction. Interestingly, pore formation,
a phenomenon commonly associated with caspase-1-mediated pyroptosis, occurred;
however, unlike its role in S. typhimurium-induced pyroptosis, pore formation did not
contribute to RB51-induced proinflammatory cell death. Our data suggest that caspase-2
acts as an initiator caspase that mediates a novel RB51-induced hybrid cell death that
simulates but differs from typical non-proinflammatory apoptosis and caspase-1-mediated
proinflammatory pyroptosis. The initiator role of the caspase-2-mediated cell death
was also conserved in cellular stress-induced cell death of macrophages treated with
etoposide, naphthalene, or anti-Fas. Caspase-2 also regulated caspase-3 and -8 activation,
as well as cell death in macrophages treated with each of the three reagents. Taken
together, our data has demonstrated that caspase-2 can play an important role in mediating
a proinflammatory response and a hybrid cell death that demonstrates features of both
apoptosis and pyroptosis.
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INTRODUCTION
Programmed cell death (PCD) is a crucial process initiated by the
host in response to cellular stress and microbial infections. PCD
can occur in a variety of ways (Galluzzi et al., 2012). Apoptosis,
pyroptosis, and necroptosis are three pathways of PCD that can
occur duringmicrobial infections with substantially different out-
comes. Apoptosis is a silent PCD due to a lack of cytokine secre-
tion (Elmore, 2007). Although the plasma membrane remains
intact, apoptotic bodies can bleb off and be phagocytosed by other
phagocytic cells in the surrounding area. Pyroptosis or “death
by fire,” is inflammatory PCD typically mediated by caspase-1
(Bergsbaken et al., 2009). Caspase-1 processes proinflammatory
cytokines (IL-1β and IL-18), and secretion of these cytokines
requires pore formation in the plasma membrane, which leads
to cell swelling and eventually lysis. Necroptosis is a newly iden-
tified type of PCD that includes a proinflammatory response as
well as loss of plasma membrane integrity (Vandenabeele et al.,
2010). In contrast to apoptosis and pyroptosis, serine/threonine
kinases, RIP1 and RIP3, mediate necroptosis. In addition, necrop-
tosis leads to the release of intracellular contents; mostly damage
associated molecular patterns (DAMPs).
Many microbes can induce cell death during infection and dis-
semination (Gao and AbuKwaik, 2000). AvirulentMycobacterium
induces apoptosis in macrophages (Fratazzi et al., 1999).
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Neighboring uninfected macrophages, upon phagocytosis, killed
Mycobacterium in apoptotic bodies released by Mycobacterium-
infected macrophages. In addition, apoptotic blebs from bacte-
rially infected cells induce a TH17 response. In contrast, Shigella
and Salmonella-induced pyroptosis leads to the release and expo-
sure of bacteria to reactive oxygen species (ROS) and neutrophils
(Hilbi et al., 1998; Brennan and Cookson, 2000;Miao et al., 2010).
In addition to bacterial pathogens, parasitic and viral pathogens
such as Trypanosoma cruzi and Vaccinia virus also have the abil-
ity to induce apoptosis and necroptosis, respectively (Cho et al.,
2009; Duaso et al., 2011). The outcomes of necroptosis are an
increase in cytokine secretion and leukocyte infiltration as well
as ROS production. As illustrated from previous studies, PCD
can play an important role in controlling microbial infections.
Meanwhile, many pathogens can inhibit these PCD pathways
in various approaches. For example, virulent wild type (WT)
Brucella strains typically inhibit PCD of infected macrophages
(Chen and He, 2009; Chen et al., 2011; Li and He, 2012).
Elucidating the PCD mechanism induced or inhibited by such
pathogens is critical to uncovering mechanisms of pathogenesis,
as well as protective immunity.
The main executors of the PCD process are caspases, which are
divided into two groups: initiators and effectors. Initiator caspases
activate effector caspases via cleavage whereas effector caspases
initiate cell death by cleaving various downstream apoptotic pro-
teins. C. elegans has a single caspase, Ced-3, that mediates all cell
death. Of 13 caspases existing in mammalian systems, caspase-
2 has the highest sequence homology with Ced-3 (Hengartner,
1997; Geng et al., 2009). Caspase-2 plays important biological
roles from oocyte development to aging control, and in interme-
diary development stages including DNA damage repair, tumor
prevention, and infection control (Guo et al., 2002; Ho et al.,
2009; Shi et al., 2009; Bouchier-Hayes and Green, 2012). Caspase-
2 can play different roles due to its unique domain structure,
which resembles an initiator and effector caspase. It contains
a caspase activation and recruitment domain (CARD) which
is required for auto-activation and binding to other molecules.
Caspase-2 also contains a cleavage site (Hofmann et al., 1997)
which resembles that of the effector caspase-3 (Talanian et al.,
1997). These factors make the classification of caspase-2 diffi-
cult. Caspase-2-deficient mice develop without an overt pheno-
type although only mild apoptotic defects in oocyte and neuron
developments were exhibited, suggesting that the function of
caspase-2 is largely redundant for cellular homeostasis during
development (Bergeron et al., 1998). Caspase-2 has been shown
to be instrumental in bacterial infections. Caspase-2 played a
role in both caspase-1-dependent and -independent apoptosis of
macrophages infected with Salmonella (Jesenberger et al., 2000).
The various and often controversial roles of caspase-2 in different
organisms and experimental conditions have been documented
and discussed (Troy and Ribe, 2008; Kitevska et al., 2009). The
role of caspase-2 in regulating cell death and the exact mechanism
remain unclear.
We previously demonstrated that rough attenuated Brucella
abortus strain RB51 induces caspase-2-mediated, caspase-1-
independent apoptotic and necrotic cell death (Chen and
He, 2009). As a licensed cattle vaccine strain, RB51 is able
to induce IFNγ and CD8+ T cell mediated cytotoxicity in
mice (He et al., 2001). Unlike its virulent counterparts, RB51
does not replicate in macrophages but it induces robust
caspase-2-mediated apoptotic and necrotic cell death (Chen
and He, 2009). In addition, RB51 induces cell death in
dendritic cells (Li and He, 2012). However, the caspase-2-
mediated RB51-induced cell death pathway is largely unknown.
Previously, we showed that caspase-2 activation as well as
decrease of the mitochondrial membrane potential occurred
in dying macrophages infected with RB51 (Chen and He,
2009). These characteristics would suggest that apoptosis via
the mitochondria-driven intrinsic pathway was the cell death
mechanism. We also showed that rough attenuated B. suis
strain VTRS1 induces caspase-2-mediated proinflammatory cell
death, which we tentatively named “caspase-2-mediated pyrop-
tosis” (Chen et al., 2011). It is likely that RB51 also induces
proinflammatory response that differs inherently from non-
proinflammatory apoptosis. How RB51 induces cell death
remains unclear.
Here we investigated which PCD mechanism was responsi-
ble for RB51-induced cell death in macrophages. We found that
RB51-infected macrophages exhibited mitochondrial dysfunc-
tion, activation of the caspase cascade (caspase-3 and caspase-8),
IL-1β and TNFα secretion, and pore formation in the plasma
membrane—all of which were dependent upon caspase-2. In
addition to infection, we found that caspase-2 also mediated
cell death as well as caspase-3 and -8 activation in macrophages
treated with etoposide, naphthalene, and anti-Fas. These results
illustrate that RB51-induced caspase-2-mediated macrophage cell
death is unique in that it exhibits characteristics of both non-
proinflammatory apoptosis and caspase-1-mediated proinflam-
matory pyroptosis.
RESULTS
CASPASE-2 MEDIATES RB51-INDUCED CELL DEATH VIA INTRINSIC
AND EXTRINSIC APOPTOSIS PATHWAYS
Our previous experiments using a chemical inhibitor and
siRNA demonstrated that caspase-2 mediates RB51-induced
macrophage cell death (Chen and He, 2009). To confirm the
caspase-2 mediated cell death, WT and caspase-2 deficient
(casp2−/−) bone-marrow derived macrophages (BMDMs) were
infected with RB51, and cell death was assessed by Annexin
V/propidium iodide (PI) staining and lactate dehydrogenase
(LDH) release. The RB51 infection was confirmed to induce
strong macrophage cell death as shown at 24 h post-infection
(h.p.i., Figures S1A,B). In contrast, casp2−/− BMDMs exhibited
little or no cell death throughout infection and only reached 8.5±
4.7% and 8.9 ± 5.1% at 24 h.p.i. in Annexin V/PI and LDH
release assays, respectively. These results confirmed that RB51-
induced cell death is mediated by caspase-2. We also assessed
if there was any difference in terms of intracellular RB51 sur-
vival inside infected WT or caspase-2 deficient macrophages. Our
study showed that the casp2−/− BMDMs were able to kill RB51
just as efficiently as WT BMDM (without statistically significant
difference) (Figure S1C). Therefore, any differences in initiating
cell death were not likely due to a lack of infectivity or bacterial
killing in casp2−/− BMDMs.
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Table 1 | Cell death measurements in caspase-2 deficient and
caspase-3 and -8 inhibited macrophages.
Condition % Cell death (±SD)
Untreated 0.7 ± 0.9
WT BMDMs 84.7 ± 1.7
Casp2KO BMDMs 12.7 ± 2.5
Z-DEVD-FMK (Casp3 inhibitor) 57.3 ± 2.1
Z-IETD-FMK (Casp8 inhibitor) 65.7 ± 3.7
Z-DEVD-FMK + Z-IETD-FMK 36.3 ± 2.5
Percent ± SD of n ≥ 3 independent experiments. Cells were counted in ran-
domly selected fields of 100 cells. All conditions except untreated where in the
presence of RB51 (MOI 200).
Since caspase-2 is required for RB51 induced cell death, we
assessed which PCD pathway caspase-2 was mediating RB51-
induced cell death. Inhibition of caspase-3 and/or caspase-8 activ-
ity led to a decrease in cell death, however, it was not as significant
as caspase-2 deficiency (Table 1). Inhibition of caspase-3 or -8 in
RB51-infected macrophages resulted in 57.3 ± 2.1% and 65.7 ±
3.7% cell death, respectively (P <0.001) (Table 1). Inhibition of
both caspase-3 and -8 led to only 36.3 ± 2.5% cell death, suggest-
ing the two types of inhibitions are likely additive but may also
be synergistic. These data suggest that RB51-induced cell death
may involve the apoptotic pathways associated with caspase-3 and
caspase-8.
Classically, caspase-3 and caspase-8 are linked to intrin-
sic (intracellular signal driven) and extrinsic (death receptor
driven) apoptotic pathways, respectively (Elmore, 2007). Both
pathways are linked to caspase-2 by mediating mitochondrial
cytochrome c release and caspase-8 activation (Lin et al., 2004;
Upton et al., 2008). To assess if caspase-2 regulated these path-
ways during RB51 infection, we investigated caspase-3 and
caspase-8 activation in WT and casp2−/− BMDMs by mea-
suring cleavage. The cleavage of both caspase-3 and caspase-8
was abolished in RB51-infected casp2−/− BMDMs (Figure 1A).
Inhibition of caspase-3 and -8 did not affect caspase-2 acti-
vation (Figure S2). Previous studies illustrated that both the
intrinsic and extrinsic cell death pathways can propagate sig-
naling by inducing mitochondrial dysfunction, which eventually
leads to cell death. Therefore, we investigated if caspase-2 medi-
ated mitochondrial dysfunction in RB51-infected macrophages.
Previously we observed that in RB51-infected macrophages,
mitochondrial membrane potential decreased over time, suggest-
ing that mitochondrial cytochrome c release (a marker of mito-
chondrial dysfunction) occurs. We found that in WT BMDMs,
cytochrome c release increased throughout infection, how-
ever, in casp2−/− BMDMs cytochrome c release was abolished
(Figure 1A).
To assess if mitochondrial dysfunction contributed to RB51-
induced cell death, the cytochrome c release was blocked with
cyclosporin A (CsA) in RB51-infected RAW264.7 (murine)
macrophages. CsA prevents opening of the mitochondrial per-
meability transition pore (MPTP), a pore responsible for
the release of mitochondrial contents such as cytochrome c
(Handschumacher et al., 1984). In the presence of CsA, cell
FIGURE 1 | Caspase-2 drives both the intrinsic and extrinsic cell death
pathways. (A) caspase-3 and -8 cleavage (activation) as well as
cytochrome c (cyto c) release in Live RB51-infected WT and casp2−/−
BMDMs. β-actin served as a loading control. UT and ET represent untreated
and etoposide (25μM, 6hr treatment), respectively. Immunoblots are
representatives of n ≥ 3 independent experiments. (B) LDH release in Live
RB51-infected RAW264.7 macrophages in the presence of cyclosporin A
(CsA; inhibitor of mitochondrial permeability transition pore, 10μM) and
Anti-TNFα (10μg/mL). Error bars represent mean ± SD of n ≥ 3
independent experiments. ∗∗p < 0.001 and ∗∗∗p < 0.0001, Student’s t-test.
n.s. = not significant. Immunoblots are representatives of n ≥ 3
independent experiments.
death was significantly reduced (p < 0.0001) in RB51-infected
macrophages (Figure 1B). Seeing that mitochondrial dysfunc-
tion occurs and both caspase-3 and caspase-8 are activated,
we explored if RB51-induced cell death was acting through
the extrinsic pathway. Extrinsic or death receptor mediated
cell death can be activated by Fas ligand (FasL) and TNFα.
Since live attenuated B. suis strain VTRS1 induces a proin-
flammatory response (Chen et al., 2011), we investigated if
TNFα played a role in mediating RB51-induced cell death. We
treated RAW264.7 macrophages with anti-TNFα and assessed cell
death via LDH release. Anti-TNFα treatment led to a decrease
in LDH release when compared to untreated RB51-infected
RAW264.7 macrophages (Figure 1B, 85.5 ± 5.1% vs. 21.4 ±
6.5%, respectively). These observations suggest that caspase-
2 drives the extrinsic cell death pathway in RB51-infected
macrophages, and the TNFα cytokine that triggers the extrin-
sic cell death pathway is likely secreted from RB51-infected
macrophages. It is also possible that the production of internal
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TNFα from amacrophage cell plays an important role of the PCD
of the same macrophage cell.
CASPASE-2 REGULATES CASPASE-1 ACTIVATION AND IL-1β
PRODUCTION IN RB51-INFECTED MACROPHAGES
Studies have illustrated that a proinflammatory response can be
the trigger or product of cell death (Elmore, 2007; Bergsbaken
et al., 2009). In addition to trigger extrinsic apoptotic cell death
pathway, TNFα is also an important proinflammatory cytokine.
Since TNFα played a role in RB51-induced cell death, we assessed
if caspase-2 mediated TNFα production. Over time, TNFα levels
increased in RB51-infected WT BMDMs. However, in casp2−/−
BMDMs, TNFα was reduced to untreated levels (Figure 2A). In
addition, CsA treatment led to a decrease in TNFα production.
Another cytokine associated with proinflammatory cell death
is IL-1β. During pyroptosis, caspase-1 processes IL-1β and aids
FIGURE 2 | Caspase-2 drives proinflammatory responses in
RB51-infected macrophages. (A) TNFα and (B) IL-1β levels in WT,
casp2−/−, CsA (cyclosporin A, inhibitor of mitochondrial permeability
transition pore, 10μM) and Z-WEHD-FMK (caspase-1 inhibitor, 20μM)
treated BMDMs. Error bars represent mean ± SD of n ≥ 3 independent
experiments. ‡, ∗p < 0.01 and ‡ ‡ ‡, ∗∗∗p < 0.0001, Student’s t-test. (∗, ∗∗∗)
and (‡, ‡ ‡ ‡) represent comparison to untreated and WT + Live RB51,
respectively. (C) caspase-1 cleavage (activation) in Live RB51-infected WT
and casp2−/− BMDMs. UT represents untreated (negative control).
Immunoblots are representatives of n ≥ 3 independent experiments.
in its secretion. Interestingly, caspase-2 contains a CARD domain
and has been shown to mediate caspase-1 activation during
Salmonella infections (Jesenberger et al., 2000). Similar to TNFα,
IL-1β levels increased above untreated levels starting at 6 h.p.i.,
however, in casp2−/− and caspase-1 inhibited BMDMs, IL-
1β production was abolished (Figure 2B). In the presence of
CsA, IL-1β levels were significantly reduced in RB51-infected
macrophages. A decrease in IL-1β levels in casp2−/− BMDMs
suggested that either caspase-2 regulates caspase-1 activation
or caspase-2 is directly responsible for the processing of IL-
1β. To evaluate these two possibilities, caspase-1 cleavage in
RB51-infected WT and casp2−/− BMDMs was measured. RB51
induced caspase-1 cleavage in WT BMDMs starting at 6 h.p.i.,
however, cleaved caspase-1 was absent in casp2−/− BMDMs
(Figure 2C). These data suggest that caspase-2, via mitochondrial
dysfunction, mediates caspase-1 activation and IL-1β production
in RB51-infected macrophages.
PORE FORMATION IS NOT REQUIRED FOR RB51-INDUCED CELL DEATH
Caspase-1 activation and IL-1β production are key indicators
of pyroptosis. During pyroptosis, pores form in the plasma
membrane, leading to a change in ionic gradient and water
influx. The consequence of the pores is cell swelling, due to
water influx, and eventually cell lysis. Salmonella enterica serovar
Typhimurium SL1344 is a pathogen known for inducing pyrop-
tosis in macrophages (Fink and Cookson, 2006). We hypoth-
esized that RB51 induced pore formation in macrophages. To
test this, SL1344- and RB51-infected RAW264.7 macrophages
were separately stained with two membrane impermeant dyes,
ethidium bromide (EtBr, 394 Da) and the larger sized ethid-
ium homodimer-2 (EthD2, 1293 Da). Uptake of EtBr and EthD2
would represent discrete pore formation and loss of plasma
membrane integrity, respectively. Gliotoxin (apoptosis inducer)
treated RAW264.7 macrophages excluded both impermeant
dyes (Figure 3A), indicative of an intact plasma membrane. In
SL1344- and RB51-infectedWT BMDMs, uptake of EtBr began at
1 h.p.i. and increased throughout infection (Figure 3A). Uptake
of EthD2 was significantly less than EtBr and did not occur until
6 h.p.i. and 24 h.p.i. in RB51- and SL1344-infected macrophages,
respectively (Figure 3A and Figure S3A). Since pore formation
has been shown to be dependent upon caspase-1, it was not sur-
prising to see that uptake of both EtBr and EthD2 were abolished
in RB51-infected casp2−/− and caspase-1 inhibited WT BMDMs
(Figure 3A and Figure S3B).
We further assessed if pore formation in RB51-infected
macrophages contributed to RB51-induced cell death. RB51-
infected macrophages were treated with glycine, a cytoprotective
agent. Glycine prevents cell death by stabilizing the ion gradient
(Frank et al., 2000). Glycine treatment decreased SL1344-induced
macrophage cell death, however, no effect was seen with RB51
(Figure 3B). These findings demonstrate that although pore for-
mation occurs in RB51-infected macrophages, it is not the cause
of the RB51-induced macrophage cell death.
CASPASE-2 MEDIATES CELL DEATH IN OTHER CONTEXTS
Since caspase-2 can regulate cell death in the context of a
Brucella infection, we investigated if caspase-2 also plays a critical
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FIGURE 3 | Pore formation does not contribute to RB51-induced cell
death. (A) WT and casp2−/− BMDMs treated with Gliotoxin (10μM, 6h
treatment) or infected with RB51 were stained with the membrane
permeable dye Hoechst 33342 (blue) and the membrane impermeant dyes
(red), EtBr (MW 394) or EthD2 (MW 1293). Adherent cells were visualized by
fluorescence microscopy (100x). Images are representatives of n ≥ 3
independent experiments. (B) LDH release in Live RB51 and SL1344-infected
RAW264.7 macrophages in the absence or presence of glycine (5mM). Error
bars represent mean ± SD of n ≥ 3 independent experiments. ∗∗p < 0.001
and ∗∗∗p < 0.0001, Student’s t-test. n.s. = not significant.
role in the presence of different cell death chemical inducers—
etoposide, naphthalene, anti-Fas, and gliotoxin. Etoposide and
naphthalene are DNA damaging agents that trigger mitochon-
drial ROS production, inducing cell death via the intrinsic path-
way (Gorman et al., 1997; Bagchi et al., 1998, 2001; Pham and
Hedley, 2001). Treatment with anti-Fas antibody mimics acti-
vation of death receptor signaling by FasL through the extrinsic
pathway. (Aggarwal and Gupta, 1999). Gliotoxin mediates Bak
activation leading to cytochrome c release from the mitochondria
and cell death (Pardo et al., 2006). To assess the role of caspase-
2 in the presence of these chemical inducers, we first assessed
caspase-2 activation. In macrophages treated with etoposide,
naphthalene, and anti-Fas, caspase-2 was activated. However,
gliotoxin did not induce caspase-2 activation (Figure 4A). Next,
we investigated if caspase-2 mediated cell death in the presence
of these inducers via Annexin V/PI staining. All four chemicals
induced cell death after 6 h of treatment. The caspase-2 deficiency
led to a significant decrease in cell death in etoposide, naphtha-
lene, and anti-Fas treated but not gliotoxin treated macrophages
(Figure 4B).
Knowing the mechanism by which these chemical induc-
ers mediate cell death, we assessed whether caspase-3 and -
8 activation occurred and whether caspase-2 mediated their
activation as seen in RB51-infected macrophages. Caspase-3
was activated in etoposide, naphthalene, anti-Fas, and gliotoxin
treated WT BMDMs (Figure 4C). Caspase-3 activation was
abolished in casp2−/− BMDMs treated with etoposide, naph-
thalene, and anti-Fas but not gliotoxin. Caspase-8 activation
was observed in etoposide, naphthalene, and anti-Fas treat-
ment yet absent during gliotoxin treatment (Figure 4C). Similar
to caspase-3, caspase-8 activation was abolished in etoposide,
naphthalene, anti-Fas treated casp2−/− BMDMs. These data
indicate that caspase-2 can exhibit a crucial role in medi-
ating cell death initiated by other stimuli besides microbial
infection.
DISCUSSION
Here we report that RB51-induced cell death is driven by the
caspase-2/mitochondrial axis. Our results demonstrated that
RB51-infected macrophages induce the caspase-2 activation, and
the activated caspase-2 mediates caspase-1, -3, and -8 activa-
tions, and TNFα and IL-1β secretions. Mitochondrial release
of cytochrome c was associated with caspase-3 activation and
contributed to RB51-induced cell death. Although pores formed
in the plasma membrane upon infection, they did not con-
tribute to cell death. In addition to cell death, we showed
that the RB51-induced proinflammatory response was medi-
ated by caspase-2 and mitochondrial dysfunction. In addition
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FIGURE 4 | Caspase-2 mediates caspase-3 and -8 activation in other
contexts. (A) Caspase-2 cleavage (activation) in Live RB51-infected
RAW264.7 macrophages. UT, ET, NT, α-Fas, and GT represent untreated,
etoposide (25μM, 6h treatment), Naphthalene (100μM, 6h treatment),
Anti-Fas (1μg/mL, 6 h 4 treatment), and Gliotoxin (10μM, 6h treatment),
respectively. (B) ET, NT, α-Fas, GT treated WT and casp2−/− BMDMs were
stained with Annexin V/propidium iodide (PI). Adherent cells were visualized
by fluorescence microscopy (100x). Cells were counted in randomly selected
fields of 100 cells. Images are representatives of n ≥ 3 independent
experiments. (C) Caspase-3 and −8 cleavage (activation) in ET, NT, α-Fas, GT
treated WT and casp2−/− BMDMs. Immunoblots are representatives of
n ≥ 3 independent experiments.
to microbial infections, caspase-2 also demonstrated a con-
tributing role in mediating cell death with different cell death
inducers.
Rough Brucella species are known to induce PCD (Freeman
et al., 1961; Fernandez-Prada et al., 2003; Pei et al., 2006) as
well as a robust immune response (Rittig et al., 2003). Here
we show that proinflammatory cytokine TNFα plays a critical
role in RB51-induced macrophage cell death, however, TNFα
appears not to play an important role in macrophage cell death
induced by the infection of strain CA180, another B. abortus
rough strain (Pei et al., 2006). Although both RB51 and CA180
share a rough Brucella lipopolysaccharide (LPS) phenotype (i.e.,
containing deficient O antigen on their LPS), the LPS pheno-
type patterns in these two strains are likely different. CA180 has a
truncated core polysaccharide due to a mutation in the phospho-
mannomutase gene (Allen et al., 1998). Phosphomannomutase
is needed to the elongation of the polysaccharide core. The
polysaccharide core has been shown to elicit cytokine production,
any changes (e.g., shortening) can decrease cytokine produc-
tion (Otterlei et al., 1993; Berntzen et al., 1998). The rough
phenotype of RB51 is primarily due to the mutation of a gene
wboA that encodes for a glycosyltransferase required for O-side
chain sysnthesis (Vemulapalli et al., 1999). Additional mutation
also exists in RB51 (Marianelli et al., 2004). Rough mutants
with different gene mutations are known to possibly induce
different phenotypes (Gonzalez et al., 2008). Therefore, the dif-
ferent gene mutations in RB51 and CA180 may explain the
difference in the role of TNFα in the induced macrophage cell
death.
Although caspase-2 has been linked to many different cellu-
lar processes, caspase-2 is still considered primarily a proapop-
totic caspase. Here we show that caspase-2 can mediate IL-
1β production, as well as caspase-1 activation. In addition to
Brucella infection, caspase-2 has also been shown to regulate
caspase-1 activation in Salmonella infected macrophages. We
speculate that caspase-2 might regulate caspase-1 by interact-
ing with the inflammasome complexes responsible for caspase-1
activation or by inducing an inflammasome trigger (e.g., ER
stress, mitochondrial DNA release, or ROS production). Caspase-
1 interacts with different inflammasome proteins and acces-
sory proteins via its CARD domain. Inflammatory caspases
(caspase-1, −4, −5, −11) interact with inflammasome and acces-
sory proteins via their CARD domain. Caspase-2 also contains
a CARD domain. Further investigation into whether caspase-2
can interact with different inflammasome components is needed.
Another possible mechanism for caspase-2 regulation of caspase-
1 activation is through mitochondrial dysfunction. As seen with
CsA treatment, there was a sharp decrease in IL-1β produc-
tion suggesting that the mitochondria can aid in inflamma-
some activation during RB51 infection. Recent studies have
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linked NLRP3 and AIM2 activation to mitochondrial dysfunc-
tion (Nakahira et al., 2011; Misawa et al., 2013; Subramanian
et al., 2013). It is possible that caspase-2-induced mitochon-
drial dysfunction leads to release of mitochondrial danger
associated molecular patterns (DAMPs). Mitochondrial DAMPs
(e.g., mtDNA or cardiolipin exposure) can lead to NLRP3 and
AIM2 inflammasome activation (Nakahira et al., 2011). Caspase-
2 has been linked to mediating mitochondrial dysfunction—
caspase-2 cleaves Bid leading to mitochondrial outer membrane
pore formation and eventually release of mitochondrial con-
tent (e.g., cytochrome c). Whether caspase-2-mediated release
of mitochondrial DAMPs is the mechanism by which the
inflammasome and caspase-1 activation occurs remains to be
elucidated.
The caspase-2-mediated cell death pathway seen in RB51-
infected macrophages differs from classical apoptosis, caspase-
1-mediated pyroptosis, and necroptosis (Table 2). RB51-induced
cell death is not mediated by caspase-1. Our data suggest that
RIP1 and RIP3 (mediators of necroptosis) are not active because
both caspase-2 and -8 activated by RB51 infection can cleave
RIP1 and RIP3—the cleavage of these two prevents necropto-
sis from occurring (Lin et al., 1999; Lamkanfi et al., 2005). In
addition, RB51-infected macrophages secrete proinflammatory
Table 2 | Comparison of caspase-2-mediated cell death to classical
apoptosis and pyroptosis.
Apoptosis Casp-1
pyroptosis
Necroptosis Casp2-mediated
cell death
Plasma
membrane pore
formation
− + − +
Loss in plasma
membrane
integrity
− +
(swelling =
lysis)
+ +
(6 and 24 h.p.i.)
Loss of
mitochondrial
membrane
potential
+ − + +
Cytochrome c
release
+ − + +
Proinflammatory − + + +
Caspase-1
mediated
− + − −
Caspase-2
mediated
+/− − − +
Caspase-3
activation
+ − − +
Caspase-8
activation
+/−
(extrinsic)
− − +
ROS production + − + +
Release of
DAMPs
− + + +
RIP1/3-mediated − − + ?
+, occurs; −, does not occur; +/−, may occur but not required; ?, unknown.
cytokines starting at 6 h.p.i., a characteristic absent in apoptosis.
Caspase-1 is active and contributes to IL-1β production. However,
unlike the phenomenon seen in caspase-1-mediated pyropto-
sis, neither caspase-1 nor the pore in the plasma membrane
contributes to cell death. Our data suggest that RB51-induced
caspase-2-mediated cell death does not fall into any of the three
classical PCD pathways. The term “pyroptosis” was originally
coined to indicate proinflammatory (=“pyro”) PCD (“=ptosis”)
(Bergsbaken et al., 2009). Owing to the common feature of
caspase-mediated proinflammatory cell death between caspase-
1-mediated pyroptosis and caspase-2-mediated cell death, previ-
ously we tentatively labeled the caspase-2-mediated proinflam-
matory cell death as “caspase-2-mediated pyroptosis” (Chen et al.,
2011). Considering that current study also clearly shows that
caspase-2 also mediates apoptosis-like features (e.g., caspase-3
and -8 activation and loss of mitochondrial membrane potential)
(Table 2), caspase-2 appears to mediate a hybrid cell death that
includes partial features of both non-proinflammatory apoptosis
and caspase-1-mediated proinflammatory pyroptosis. Although
distinct, caspase-2-mediated cell death and necroptosis appear to
also share some similarities as well (Table 2).
In addition to RB51, rough attenuated B. abortus strain RA1
(Chen and He, 2009) and B. suis strain VTRS1 also induces
caspase-2-mediated macrophage cell death (Chen et al., 2011).
However, their parent WT strains 2308 and 1330 do not induce
macrophage cell death. Our recent study found that caspase-2
also mediates PCD of dendritic cells infected with RB51 and its
WT strain 2308 (Li and He, 2012). The induction of caspase-
2-mediated cell death in strain 2308-infected dendritic cells but
not in strain 2308-infected macrophages facilitates the survival of
the virulent strain inside macrophages and avoidance of Brucella
antigen presentation inside dendritic cells (Li and He, 2012). It is
likely that such caspase-2-mediated host cell death is also induced
or inhibited by other infectious microbes, such as live attenuated
vaccine strains or virulent pathogens of intracellular bacteria and
viruses.
Our studies on the relationship between caspase-2 and cell
death induced by different cell death inducers further illustrate
the critical and conserved role and the mechanism of caspase-
2 in triggering PCD. Both etoposide and naphthalene are DNA
damage inducers, a stimulus known for activating caspase-2.
Interestingly, both etoposide and naphthalene induced caspase-8
activation. Previous studies have illustrated a connection between
DNA damage, caspase-8, and caspase-2. Both caspase-2 and
caspase-8 can be activated by p53 (Seth et al., 2005; Liu et al.,
2011); this suggests that upon etoposide and naphthalene treat-
ment, p53 activates caspase-2 leading to caspase-8 activation.
Anti-Fas works through the extrinsic pathway and leads to cell
death via caspase-8 dependent activation of caspase-3. Seeing
that caspase-2 aided in caspase-8 activation (outside of DNA
damage) clearly suggests that caspase-2 can act as an initia-
tor caspase to mediate activation of other caspases. Whether
caspase-2 mediates caspase-8 activation directly or indirectly
remains unclear. Gliotoxin induced cell death via the intrin-
sic pathway. Only caspase-3 was activated in gliotoxin-treated
macrophages. Cytochrome c can aid in caspase-2 activation,
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however, (Slee et al., 1999), in the context of gliotoxin intox-
ication this was not the case because caspase-2 activation did
not occur. Gliotoxin acts on Bak and its downstream tar-
get t-Bid [a known target cleaved by caspase-2, (Upton et al.,
2008)]; therefore, it is possible that gliotoxin short-circuits
the classical intrinsic pathway and does not require signaling
components upstream of the mitochondria. In the case of etopo-
side and naphthalene, the data suggest that caspase-2 regulates
caspase-3 activation via the mitochondria. Caspase-3 is acti-
vated via the apoptosome, a multiprotein complex dependent
upon cytochrome c release. Caspase-2 was previously reported
to act upstream of caspase-8 during ceramide-induced mito-
chondrial apoptosis in T cells (Lin et al., 2004). It appears
that the caspase-2 regulation of caspase-3 and -8 can occur
in different cell types with different treatments, so this type
of regulation is neither cell specific nor context specific. These
observations suggest that caspase-2 can play a critical role in
initiating PCD.
The caspase-2-mediated cell death pathway is likely critical
to microbial pathogenesis and host immunity. In the context
of RB51, cell death and the proinflammatory response may
have synergistic effects on host immune responses. Cell death
may result in the exposure of RB51 to a more hostile extra-
cellular environment (as seen in pyroptosis and necroptosis).
In addition, neighboring macrophages and dendritic cells may
recognize processed RB51 antigens leading to cross priming of
CD8+ T cells (important for RB51-induced protective immu-
nity). We recently showed that RB51 induced cell death in
bone marrow derived dendritic cells and aided in maturation as
well as priming of T cells—all of which were dependent upon
caspase-2 (Li and He, 2012). These observations demonstrate the
importance for caspase-2, as well as cell death, in initiating the
immune response. Utilizing this PCD pathway may ensure that
the host triggers a potent immune response. Prevention of this
pathway may aid in enhancing survival of virulent Brucella in
macrophages. Our previous work suggested prevention—virulent
strain B. abortus S2308 did not induce caspase-2 activation nor
cytochrome c release in infected macrophages (Chen and He,
2009).
Caspase-2 is also implicated in other processes (cancer reg-
ulation and metabolism) and may take on a regulatory role
in these processes as well. We have made an original obser-
vation that caspase-2 plays a non-redundant role in triggering
the proinflammatory cell death of RB51-infected macrophages
and in macrophages treated with various drugs. After the evolu-
tion of complex caspase-cascade cell death signaling pathways in
advanced animals, it is suggestive that the protein functions of the
highly conserved caspase-2 have been preserved during evolution
and serve as safeguards to regulate various cell death pathways.
It is likely that intracellular pathogens with similar lifestyles to
Brucella (e.g., Salmonella, Mycobacterium, Listeria, Francisella,
and Legionella) may utilize caspase-2 during infection. Further
understanding of caspase-2-mediated pyroptosis can aid in sup-
plying a blueprint for effective brucellosis vaccines (both animals
and humans) as well as effective therapeutics against cancers and
other diseases.
MATERIALS AND METHODS
MICE
The caspase-2 knockout (Casp2KO) mice were originally gener-
ated by Junying Yuan and kindly provided by Dr. Brian Herman
of the University of Texas Health Science Center at San Antonio
with Dr. Yuan’s consent (Bergeron et al., 1998). The deletion
inactivates both the long and short form of caspase-2. The mice
were backcrossed with C57BL/6 once in the Unit for Laboratory
Animal Medicine at the University of Michigan Medical School,
and then used as founders. Casp2KO and WT C57BL/6 (Jackson)
mice with similar ages were applied in the experiments. The
University Committee on Use and Care of Animals (UCUCA) at
the University of Michigan approved the protocol (#09695) to use
mice for studies described here.
BACTERIAL STRAINS AND REAGENTS
RAW264.7 macrophages and bone marrow derived macrophages
(BMDMs) were infected with Brucella abortus strain RB51
(from Dr. G. Schurig, Virginia Polytechnic Institute and State
University) and Salmonella typhimurium SL1344 (from Mary
O’Riordan, University of Michigan). The following inhibitors
and inducers were used: CsA (Sigma-Aldrich), etoposide (Sigma-
Aldrich), naphthalene (Sigma-Aldrich), Anti-Fas (BioVision),
gliotoxin (-Aldrich), glycine (Sigma-Aldrich), Z-WEHD-FMK
(Caspase-1 inhibitor, R&D Systems), Z-DEVD-FMK (Caspase-
3 inhibitor, R&D Systems), Z-IETD-FMK (Caspase-8 inhibitor,
R&D Systems), and anti-TNFα (mouse specific, BioVision).
The following antibodies were used: anti-cytochrome c
(cat#:4272S, Cell Signaling), anti-caspase-3 (cat#: 9662S, Cell
Signaling), anti-caspase-8 (cat#: 4927S, Cell Signaling), anti-
caspase-2 (cat#: 3027-100, BioVision), anti-caspase-1 (cat#: sc-
514, Santa Cruz), and anti-actin (cat#: MS1295P1, Thermo
Scientific).
CELL CULTURE AND INFECTION
BMDMs were isolated from WT and casp2−/− mice on a
C57BL/6 background. Isolated BMDMs were differentiated in
DMEM (GIBCO) supplemented with 20% heat-inactivated FBS
(GIBCO), 1% L-glutamine (200mM), 1% sodium pyruvate
(100mM), 0.1% β-mercaptoethanol (55mM), and 30% L-929
fibroblast conditioned medium. BMDMs were cultured in non-
TC treated plates, fed fresh media on Day 3, and harvested on
Day 6. BMDMs were maintained at 37◦C under 5% CO2.
Four million RAW264.7 macrophages and BMDMs were
seeded in 6 well plates 18 h prior to infection. The following
day, where indicated cells were pretreated with CsA (10μM), Z-
WEHD-FMK (20μM), Z-DEVD-FMK (20μM), Z-IETD-FMK
(20μM) and Anti-TNFα (10μ g/mL) for 1 h prior to infection.
Untreated and pretreated cells were infected with RB51 (MOI
200) or SL1344 (MOI 25) for 30min, after which the inoculum
was removed and cells were washed with PBS. Medium con-
taining 50μ g/ml of gentamicin was added to kill extracellular
bacteria. To synchronize infection, cells were spun at 1200 rpm
for 3min after adding inoculum. Cells were treated with etopo-
side (25μM), naphthalene (100μM), anti-Fas (1μ g/mL), and
gliotoxin (10μM) for 6 hr. At the indicated times, cells were lysed
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in buffer containing 1% NP-40 on ice for 15min and spun at
13,000 rpm for 15min to pellet the insoluble fraction. Soluble
fractions were used for immunoblot assays.
IMMUNOBLOT ASSAY
Cytosolic extracts collected at various time points (1, 6, and
24 h pi) were separated by SDS-PAGE, transferred to PVDF
membranes (Millipore), blocked with 5% milk in TBS-Tween20
(TBS-T), and incubated overnight at 4◦C with primary anti-
bodies stated above. Membranes were washed with TBS-T and
incubated with secondary HRP conjugated to either goat anti-
rabbit IgG (cat#: 12–348,Millipore) or goat anti-mouse IgG (cat#:
1034-05, Southern Biotech) at room temperature for 1 h. Bands
were visualized using the ECL Western Blotting Substrate Kit
(Pierce). Immunoblots in the figures are representative of n ≥ 3
independent experiments.
CYTOKINE DETECTION
Culture supernatants were collected at different time points (1,
6, and 24 h pi) from macrophages infected as described above.
IL-1β and TNFα levels were determined by sandwich enzyme-
linked immunosorbent assay (ELISA) according to manufac-
turer’s instructions (BioLegend). A minimum of three technical
replicates per experiment and three experimental replicates were
analyzed for each condition.
CELL DEATH ASSAY
RAW264.7 macrophages were seeded in 6 well plates at a con-
centration 9.6 × 104 per well and infected with RB51 as stated
above. Cells were stained with Annexin V and PI using the
Annexin V-FLUOS staining kit (Roche Diagnostics Corporation).
Cells were washed with PBS and incubated with the fluorescent
dyes for 15min in the dark at room temperature. Fluorescence
was observed with a Nikon TK-2000-S microscope and pho-
tographed with a RT Slide Spot digital camera and QCapture
Pro software. Uninfected macrophages served as negative
controls.
ETHIDIUM BROMIDE (EtBr) AND ETHIDIUM HOMODIMER-2 (EthD2)
STAINING
Macrophages were grown in 6-well plates and infected as
described above. At different time points post-infection, cells
were washed with PBS (GIBCO) and stained with Hoechst 33342
(5μ g/mL) and either EtBr or EthD2 (25μ g/mL) according to the
manufacturer’s instructions. Cell were analyzed with a Nikon TK-
2000-s microscope and photographed with a RT slide spot digital
camera and QCapture Pro Software.
LACTATE DEHYDROGENASE (LDH) RELEASE ASSAY
Macrophages were seeded in 96-well plates and infected with
RB51 or SL1344 as stated above. Supernatants were ana-
lyzed for the presence of LDH enzyme using the CytoTox-
ONE™ Homogeneous Membrane Integrity Assay (Promega)
as directed by the manufacturer’s instructions. Percentage
of LDH release was calculated as 100 × [(Experimental
LDH Release—Culture Medium Background)/(Maximum LDH
Release—Culture Medium Background)].
STATISTICAL ANALYSIS
All p-values were generated between identified samples using
unpaired two-tailed Student’s t-tests and represent analysis
of ≥3 replicates per condition. ‡, ∗p < 0.01 ‡ ‡, ∗p < 0.001
and ‡ ‡ ‡, ∗∗∗p < 0.0001.
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Figure S1 | Caspase-2 mediates RB51-induced macrophage cell death. (A)
Annexin V/propidium iodide (PI) staining of RB51-infected WT and
casp2−/− BMDMs at 100X magnification. Images are representatives of
n ≥ 3 independent experiments. (B) LDH release in Live RB51-infected
WT and casp2−/− BMDMs. Cells were counted in randomly selected
fields of 100 cells. (C) CFU analysis of RB51 in WT and casp2−/−BMDMs,
Error bars represent mean ± SD of n ≥ 3 independent experiments.
∗∗p < 0.001 and ∗∗∗p < 0.0001, Student’s t-test. n.s. = not significant.
Figure S2 | Caspase-3 and -8 are involved in RB51-induced cell death. (A)
Caspase-2 cleavage (activation) in Live RB51-infected RAW264.7
macrophages with or without Z-DEVD-FMK (20μM, Caspase-3 inhibitor).
(B) Caspase-2 cleavage (activation) in Live RB51-infected RAW264.7
macrophages with or without Z-IETD-FMK (20μM, Caspase-8 inhibitor).
UNT and ET represent untreated and etoposide (25μM, 6h treatment),
respectively. Immunoblots are representatives of n ≥ 3 independent
experiments.
Figure S3 | Caspase-1 aids in RB51-induced pore formation. RB51-infected
RAW264.7 macrophages treated with Z-YVAD-FMK (20μM, caspase-1
inhibitor) were stained with the membrane permeable dye Hoechst
33342 (blue) and the membrane impermeant dyes (red), EtBr (MW 394) or
EthD2 (MW 1293). Adherent cells were visualized by fluorescence
microscopy (100x). Images are representatives of n ≥ 3 independent
experiments.
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